Premalignancies  ||| S:0 E:16 ||| NNP
of  ||| S:16 E:19 ||| IN
colon  ||| S:19 E:25 ||| VBG
The  ||| S:25 E:29 ||| DT
most  ||| S:29 E:34 ||| RBS
common  ||| S:34 E:41 ||| JJ
premalignant  ||| S:41 E:54 ||| JJ
lesions  ||| S:54 E:62 ||| NNS
of  ||| S:62 E:65 ||| IN
colorectal  ||| S:65 E:76 ||| JJ
carcinoma  ||| S:76 E:86 ||| NNS
include  ||| S:86 E:94 ||| VBP
sporadic  ||| S:94 E:103 ||| JJ
adenomas ||| S:103 E:111 ||| NN
.  ||| S:111 E:113 ||| .
Tubular  ||| S:113 E:121 ||| NNP
and  ||| S:121 E:125 ||| CC
tubulovillous  ||| S:125 E:139 ||| JJ
adenomas  ||| S:139 E:148 ||| NN
with  ||| S:148 E:153 ||| IN
mild  ||| S:153 E:158 ||| JJ
dysplasia  ||| S:158 E:168 ||| NNS
are  ||| S:168 E:172 ||| VBP
considered  ||| S:172 E:183 ||| VBN
benign  ||| S:183 E:190 ||| JJ
lesions ||| S:190 E:197 ||| NNS
,  ||| S:197 E:199 ||| ,
while  ||| S:199 E:205 ||| IN
villous  ||| S:205 E:213 ||| JJ
adenomas  ||| S:213 E:222 ||| NNS
represent  ||| S:222 E:232 ||| VBP
tumors  ||| S:232 E:239 ||| VBN
with  ||| S:239 E:244 ||| IN
uncertain  ||| S:244 E:254 ||| JJ
bio-logical  ||| S:254 E:266 ||| JJ
behavior ||| S:266 E:274 ||| NN
.  ||| S:274 E:276 ||| .
In  ||| S:276 E:279 ||| IN
recent  ||| S:279 E:286 ||| JJ
years ||| S:286 E:291 ||| NNS
,  ||| S:291 E:293 ||| ,
demonstrable  ||| S:293 E:306 ||| JJ
growth  ||| S:306 E:313 ||| NN
of  ||| S:313 E:316 ||| IN
flat  ||| S:316 E:321 ||| JJ
lesions  ||| S:321 E:329 ||| NNS
in  ||| S:329 E:332 ||| IN
the  ||| S:332 E:336 ||| DT
proximal  ||| S:336 E:345 ||| JJ
intestine  ||| S:345 E:355 ||| NN
has  ||| S:355 E:359 ||| VBZ
been  ||| S:359 E:364 ||| VBN
seen ||| S:364 E:368 ||| VBN
.  ||| S:368 E:370 ||| .
Precision  ||| S:370 E:380 ||| NNP
and  ||| S:380 E:384 ||| CC
yield  ||| S:384 E:390 ||| NN
of  ||| S:390 E:393 ||| IN
colonoscopy  ||| S:393 E:405 ||| NN
depends  ||| S:405 E:413 ||| VBZ
to  ||| S:413 E:416 ||| TO
some  ||| S:416 E:421 ||| DT
extent  ||| S:421 E:428 ||| NN
on  ||| S:428 E:431 ||| IN
good  ||| S:431 E:436 ||| JJ
preparation ||| S:436 E:447 ||| NN
,  ||| S:447 E:449 ||| ,
careful  ||| S:449 E:457 ||| JJ
screening  ||| S:457 E:467 ||| NN
of  ||| S:467 E:470 ||| IN
intestine  ||| S:470 E:480 ||| NN
and  ||| S:480 E:484 ||| CC
use  ||| S:484 E:488 ||| NN
of  ||| S:488 E:491 ||| IN
new  ||| S:491 E:495 ||| JJ
instruments  ||| S:495 E:507 ||| NNS
of  ||| S:507 E:510 ||| IN
better  ||| S:510 E:517 ||| JJR
quality ||| S:517 E:524 ||| NN
.  ||| S:524 E:526 ||| .
As  ||| S:526 E:529 ||| IN
an  ||| S:529 E:532 ||| DT
indicator  ||| S:532 E:542 ||| NN
of  ||| S:542 E:545 ||| IN
screening  ||| S:545 E:555 ||| VBG
colonoscopy  ||| S:555 E:567 ||| JJ
quality ||| S:567 E:574 ||| NN
,  ||| S:574 E:576 ||| ,
the  ||| S:576 E:580 ||| DT
so  ||| S:580 E:583 ||| JJ
-called  ||| S:583 E:591 ||| JJ
adenoma  ||| S:591 E:599 ||| JJ
detection  ||| S:599 E:609 ||| JJ
rate  ||| S:609 E:614 ||| NN
is  ||| S:614 E:617 ||| VBZ
used ||| S:617 E:621 ||| VBN
.  ||| S:621 E:623 ||| .
The  ||| S:623 E:627 ||| DT
text  ||| S:627 E:632 ||| NN
briefly  ||| S:632 E:640 ||| NN
describes  ||| S:640 E:650 ||| VBZ
options  ||| S:650 E:658 ||| NNS
of  ||| S:658 E:661 ||| IN
endoscopic  ||| S:661 E:672 ||| NN
and  ||| S:672 E:676 ||| CC
surgical  ||| S:676 E:685 ||| JJ
resolving  ||| S:685 E:695 ||| NN
of  ||| S:695 E:698 ||| IN
premalignancies ||| S:698 E:713 ||| NN
.  ||| S:713 E:715 ||| .
In  ||| S:715 E:718 ||| IN
the  ||| S:718 E:722 ||| DT
Czech  ||| S:722 E:728 ||| JJ
Republic ||| S:728 E:736 ||| NNP
,  ||| S:736 E:738 ||| ,
attendance  ||| S:738 E:749 ||| NN
in  ||| S:749 E:752 ||| IN
the  ||| S:752 E:756 ||| DT
screening  ||| S:756 E:766 ||| NN
program  ||| S:766 E:774 ||| NN
is  ||| S:774 E:777 ||| VBZ
low ||| S:777 E:780 ||| JJ
,  ||| S:780 E:782 ||| ,
which  ||| S:782 E:788 ||| WDT
could  ||| S:788 E:794 ||| MD
be  ||| S:794 E:797 ||| VB
changed  ||| S:797 E:805 ||| VBN
by  ||| S:805 E:808 ||| IN
prepared  ||| S:808 E:817 ||| JJ
addressed  ||| S:817 E:827 ||| JJ
invitations  ||| S:827 E:839 ||| NNS
of  ||| S:839 E:842 ||| IN
clients ||| S:842 E:849 ||| NNS
.  ||| S:849 E:851 ||| .
The  ||| S:851 E:855 ||| DT
population  ||| S:855 E:866 ||| NN
with  ||| S:866 E:871 ||| IN
a  ||| S:871 E:873 ||| DT
genetic  ||| S:873 E:881 ||| JJ
or  ||| S:881 E:884 ||| CC
familiar  ||| S:884 E:893 ||| JJ
risk  ||| S:893 E:898 ||| NN
is  ||| S:898 E:901 ||| VBZ
examined  ||| S:901 E:910 ||| VBN
according  ||| S:910 E:920 ||| VBG
to  ||| S:920 E:923 ||| TO
recommended  ||| S:923 E:935 ||| JJ
procedures  ||| S:935 E:946 ||| NNS
intended  ||| S:946 E:955 ||| VBN
for  ||| S:955 E:959 ||| IN
increased-  ||| S:959 E:970 ||| CD
risk  ||| S:970 E:975 ||| NN
persons ||| S:975 E:982 ||| NNS
.  ||| S:982 E:984 ||| .
